227 related articles for article (PubMed ID: 8302461)
21. Effects of citrate-enriched bicarbonate based dialysate on anticoagulation and dialyzer reuse in maintenance hemodialysis patients.
Rocha AD; Padua VC; Oliveira E; Guimaraes MM; Lugon JR; Strogoff de Matos JP
Hemodial Int; 2014 Apr; 18(2):467-72. PubMed ID: 24261328
[TBL] [Abstract][Full Text] [Related]
22. Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis.
Morgera S; Haase M; Ruckert M; Krieg H; Kastrup M; Krausch D; Vargas-Hein O; Zuckermann-Becker H; Peters H; Pohlmeier R; Neumayer HH
Nephron Clin Pract; 2005; 101(4):c211-9. PubMed ID: 16155399
[TBL] [Abstract][Full Text] [Related]
23. Simplified citrate anticoagulation for high-flux hemodialysis.
Apsner R; Buchmayer H; Lang T; Unver B; Speiser W; Sunder-Plassmann G; Hörl WH
Am J Kidney Dis; 2001 Nov; 38(5):979-87. PubMed ID: 11684550
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session.
Brunet P; Simon N; Opris A; Faure V; Lorec-Penet AM; Portugal H; Dussol B; Berland Y
Am J Kidney Dis; 2008 May; 51(5):789-95. PubMed ID: 18436089
[TBL] [Abstract][Full Text] [Related]
25. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status.
Morgera S; Schneider M; Slowinski T; Vargas-Hein O; Zuckermann-Becker H; Peters H; Kindgen-Milles D; Neumayer HH
Crit Care Med; 2009 Jun; 37(6):2018-24. PubMed ID: 19384210
[TBL] [Abstract][Full Text] [Related]
26. Regional citrate anticoagulation in chronic hemodialysis patients.
Seaton RD; Duncan KA; Pinnick RV; Diederich DA; Wiegmann TB
Trans Am Soc Artif Intern Organs; 1983; 29():414-8. PubMed ID: 6673262
[TBL] [Abstract][Full Text] [Related]
27. Improved dialyzer reuse after use of a population pharmacodynamic model to determine heparin doses.
Ouseph R; Brier ME; Ward RA
Am J Kidney Dis; 2000 Jan; 35(1):89-94. PubMed ID: 10620549
[TBL] [Abstract][Full Text] [Related]
28. Regional citrate anticoagulation for single-needle hemodialysis: a prospective clinical study.
Gubensek J; Buturovic-Ponikvar J; Ponikvar R
Blood Purif; 2007; 25(5-6):454-6. PubMed ID: 18057876
[TBL] [Abstract][Full Text] [Related]
29. Prevention of coagulation during hemodialysis by a combination of the stable prostacyclin analogue CG 4203 and low-dose heparin.
Maurin N; Ballmann M
Clin Nephrol; 1988 Jul; 30(1):35-41. PubMed ID: 3061692
[TBL] [Abstract][Full Text] [Related]
30. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
[TBL] [Abstract][Full Text] [Related]
31. Intraoperative dialysis during liver transplantation with citrate dialysate.
Winrow RM; Davis C; Halldorson JB; Ahmad S
Hemodial Int; 2009 Jul; 13(3):257-60. PubMed ID: 19515070
[TBL] [Abstract][Full Text] [Related]
32. Citrate kinetics in patients receiving long-term hemodialysis therapy.
Bauer E; Derfler K; Joukhadar C; Druml W
Am J Kidney Dis; 2005 Nov; 46(5):903-7. PubMed ID: 16253731
[TBL] [Abstract][Full Text] [Related]
33. Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load.
Buturović-Ponikvar J; Pernat AM; Ponikvar R
Ther Apher Dial; 2005 Jun; 9(3):258-61. PubMed ID: 15967002
[TBL] [Abstract][Full Text] [Related]
34. Citrate anticoagulation and divalent cations in hemodialysis.
Janssen MJ; Huijgens PC; Bouman AA; Oe PL; van der Meulen J
Blood Purif; 1994; 12(6):308-16. PubMed ID: 7865189
[TBL] [Abstract][Full Text] [Related]
35. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding.
Pinnick RV; Wiegmann TB; Diederich DA
N Engl J Med; 1983 Feb; 308(5):258-61. PubMed ID: 6848936
[No Abstract] [Full Text] [Related]
36. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
Kozek-Langenecker SA; Spiss CK; Gamsjäger T; Domenig C; Zimpfer M
Wien Klin Wochenschr; 2002 Feb; 114(3):96-101. PubMed ID: 12060975
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
Nowak G; Bucha E; Brauns I; Czerwinski R
Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
[TBL] [Abstract][Full Text] [Related]
38. Whole-blood activated coagulation time for evaluation of heparin activity during hemodialysis: a comparison of administration by single-dose and by infusion.
Wilhelmsson S; Lins LE
Clin Nephrol; 1983 Feb; 19(2):82-6. PubMed ID: 6839556
[TBL] [Abstract][Full Text] [Related]
39. Standard citrate versus sequential citrate/anticoagulant-free anticoagulation during hemodialysis: a randomized trial.
Buturovic J; Gubensek J; Cerne D; Ponikvar R
Artif Organs; 2008 Jan; 32(1):77-81. PubMed ID: 18181808
[TBL] [Abstract][Full Text] [Related]
40. Exclusive use of acid citrate dextrose for anticoagulation during extracorporeal photopheresis in patients with contraindications to heparin: an effective protocol.
Nedelcu E; Ziman A; Fernando LP; Cook K; Bumerts P; Schiller G
J Clin Apher; 2008; 23(2):66-73. PubMed ID: 18286495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
